Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
42°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Summit Therapeu ADR
(NQ:
SMMT
)
4.440
-0.070 (-1.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Summit Therapeu ADR
< Previous
1
2
3
4
5
6
7
Next >
Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2023
November 07, 2023
From
Summit Therapeutics Inc.
Via
Business Wire
Laura Chow, MD, Cancer Immunotherapy Trailblazer, Joins Summit as Senior Vice President of Clinical Development
November 02, 2023
From
Summit Therapeutics Inc.
Via
Business Wire
Ivonescimab’s Novel Mechanism of Action Highlighting Cooperative Binding to be Featured in Poster Presentation at SITC 2023
October 31, 2023
From
Summit Therapeutics Inc.
Via
Business Wire
Earnings Scheduled For November 7, 2023
November 07, 2023
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
Via
Benzinga
Western Digital, JinkoSolar, Lumentum Holdings And Other Big Stocks Moving Higher On Monday
October 30, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining more than 100 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Acurx Pharmaceuticals Share Price And Volume Are Surging Ahead Of Phase 2b Trial Data Release ($ACXP)
October 27, 2023
Via
AB Newswire
Topics
Death
Exposures
Death
Summit Therapeutics to Host Q3 2023 Financial Results & Operational Progress Call on November 7, 2023
October 26, 2023
From
Summit Therapeutics Inc.
Via
Business Wire
H. Jack West, MD, Renowned Oncologist & Lung Cancer Expert, Joins Summit Therapeutics as Vice President of Clinical Development
October 19, 2023
From
Summit Therapeutics Inc.
Via
Business Wire
Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 17, 2023
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.
Via
Benzinga
Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday
October 17, 2023
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Summit Therapeutics Appoints Proven Biotech Leader Manmeet S. Soni as Chief Operating Officer
October 16, 2023
From
Summit Therapeutics Inc.
Via
Business Wire
5 Meme Stocks to Sell Immediately, According to AI
August 22, 2023
As we move into September, the MarketMaster AI is flashing warning signals about risky equities. Sell these meme stocks right now.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal
August 19, 2023
Jiangsu Hengrui Pharma out-licensed global rights (ex-China) for a novel anti-inflammatory to One Bio of Florida in a $1 billion deal. One Bio will make an $21.5 million payment upfront along with a...
Via
Talk Markets
12 Health Care Stocks Moving In Monday's Intraday Session
August 14, 2023
Via
Benzinga
Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 14, 2023
Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration...
Via
Benzinga
Cleveland-Cliffs, United States Steel, monday.com And Other Big Stocks Moving Higher On Monday
August 14, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining around 100 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2023
August 09, 2023
From
Summit Therapeutics Inc.
Via
Business Wire
Summit Therapeutics to Host Q2 2023 Financial Results & Operational Progress Call on August 9, 2023
August 02, 2023
From
Summit Therapeutics Inc.
Via
Business Wire
AlloVir, DigitalOcean And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
June 22, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. AlloVir, Inc. (NASDAQ: ALVR) shares dipped 24.1% to $3.74 in pre-market...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 20, 2023
Via
Benzinga
Promising Data for Investigational Innovative Bispecific Ivonescimab Featured at ASCO 2023
June 04, 2023
From
Summit Therapeutics Inc.
Via
Business Wire
Ivonescimab Updated Data to be Featured at ASCO 2023
June 01, 2023
From
Summit Therapeutics Inc.
Via
Business Wire
Why Shares of Summit Therapeutics Slumped on Tuesday
May 16, 2023
The company's shares have been falling since it announced earnings late last week.
Via
The Motley Fool
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2023
May 11, 2023
From
Summit Therapeutics Inc.
Via
Business Wire
Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 16, 2023
Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering.
Via
Benzinga
Summit Therapeutics Announces First Patient Treated in Phase III HARMONi Clinical Trial Evaluating Ivonescimab (SMT112)
May 09, 2023
From
Summit Therapeutics Inc.
Via
Business Wire
Why Shares of Summit Therapeutics Soared This Week
May 05, 2023
Summit Therapeutics advanced its lead therapy into two phase 3 trials to treat non-small cell lung cancer.
Via
The Motley Fool
Summit Therapeutics Announces Initial Indications for Clinical Trials for Ivonescimab (SMT112)
May 03, 2023
From
Summit Therapeutics Inc.
Via
Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Summit Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
March 21, 2023
From
Schall Law Firm
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Summit Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
March 20, 2023
From
The Schall Law Firm
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.